Shanghai Pharmaceuticals Holding Co., Ltd SHPMY Stock
Shanghai Pharmaceuticals Holding Co., Ltd Price Chart
Shanghai Pharmaceuticals Holding Co., Ltd SHPMY Financial and Trading Overview
Contents
- Shanghai Pharmaceuticals Holding Co., Ltd Price Chart
- Shanghai Pharmaceuticals Holding Co., Ltd SHPMY Financial and Trading Overview
- Valuation Measures
- Trading Information
- Financial Highlights
- Profile of Shanghai Pharmaceuticals Holding Co., Ltd
- Q&A For Shanghai Pharmaceuticals Holding Co., Ltd Stock
| Shanghai Pharmaceuticals Holding Co., Ltd stock price | 7.6 USD |
| Previous Close | 7.6 USD |
| Open | 7.6 USD |
| Bid | 7.02 USD x 30000 |
| Ask | 7.99 USD x 30000 |
| Day's Range | 7.6 - 7.6 USD |
| 52 Week Range | 6.83 - 8.32 USD |
| Volume | 400 USD |
| Avg. Volume | 0 USD |
| Market Cap | 5.64B USD |
| Beta (5Y Monthly) | 0.214 |
| PE Ratio (TTM) | 6.6086955 |
| EPS (TTM) | 1.15 USD |
| Forward Dividend & Yield | 0.29 (3.76%) |
| Ex-Dividend Date | December 31, 2025 |
| 1y Target Est | N/A |
SHPMY Valuation Measures
| Enterprise Value | 37.52B USD |
| Trailing P/E | 6.6086955 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | 5.15 |
| Price/Sales (ttm) | 0.019566555 |
| Price/Book (mrq) | 0.49370784 |
| Enterprise Value/Revenue | 0.13 |
| Enterprise Value/EBITDA | 3.451 |
Trading Information
Shanghai Pharmaceuticals Holding Co., Ltd Stock Price History
| Beta (5Y Monthly) | 0.214 |
| 52-Week Change | 11.27% |
| S&P500 52-Week Change | 24.48% |
| 52 Week High | 8.32 USD |
| 52 Week Low | 6.83 USD |
| 50-Day Moving Average | 7.6 USD |
| 200-Day Moving Average | 7.87 USD |
SHPMY Share Statistics
| Avg. Volume (3 month) | 0 USD |
| Avg. Daily Volume (10-Days) | 0 USD |
| Shares Outstanding | 183.81M |
| Float | 303.4M |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.47 |
| Trailing Annual Dividend Yield | 6.18% |
| 5 Year Average Dividend Yield | 413.99% |
| Payout Ratio | 0.262 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 2.01% |
| Operating Margin (ttm) | 3.49% |
| Gross Margin | 10.83% |
| EBITDA Margin | 3.77% |
Management Effectiveness
| Return on Assets (ttm) | 2.38% |
| Return on Equity (ttm) | 8.12% |
Income Statement
| Revenue (ttm) | 288.08B USD |
| Revenue Per Share (ttm) | 388.42 USD |
| Quarterly Revenue Growth (yoy) | 6.40% |
| Gross Profit (ttm) | 31.21B USD |
| EBITDA | 10.87B USD |
| Net Income Avi to Common (ttm) | 5.81B USD |
| Diluted EPS (ttm) | 1.15 |
| Quarterly Earnings Growth (yoy) | 6.40% |
Balance Sheet
| Total Cash (mrq) | 41.12B USD |
| Total Cash Per Share (mrq) | 55.44 USD |
| Total Debt (mrq) | 58.83B USD |
| Total Debt/Equity (mrq) | 64.32 USD |
| Current Ratio (mrq) | 1.339 |
| Book Value Per Share (mrq) | 15.39372 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 7.35B USD |
| Levered Free Cash Flow (ttm) | -1207106432 USD |
Profile of Shanghai Pharmaceuticals Holding Co., Ltd
| Country | United States |
| State | N/A |
| City | Shanghai |
| Address | Shanghai Pharmaceutical Building |
| ZIP | 200020 |
| Phone | 86 21 6373 0908 |
| Website | https://www.sphchina.com |
| Industry | Medical Distribution |
| Sector(s) | Healthcare |
| Full Time Employees | 49608 |
Shanghai Pharmaceuticals Holding Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical and healthcare products in China and internationally. The company operates through four segments: Production, Distribution, Retail, and Others. It offers chemical and biological drugs, Chinese medicine, health care products, and medical devices to treat immunology, psychiatric and neurological, tumor, cardiovascular, digestive metabolism, psychoneurotic, neoplasm, respiratory system, and anti-infection diseases, as well as invests in equity. The company also engages in the provision of pharmaceutical distribution, warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, it engages in the operation of a network of retail pharmacy stores. Shanghai Pharmaceuticals Holding Co., Ltd. was incorporated in 1994 and is headquartered in Shanghai, China.
Q&A For Shanghai Pharmaceuticals Holding Co., Ltd Stock
What is a current SHPMY stock price?
Shanghai Pharmaceuticals Holding Co., Ltd SHPMY stock price today per share is 7.6 USD.
How to purchase Shanghai Pharmaceuticals Holding Co., Ltd stock?
You can buy SHPMY shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Shanghai Pharmaceuticals Holding Co., Ltd?
The stock symbol or ticker of Shanghai Pharmaceuticals Holding Co., Ltd is SHPMY.
Which industry does the Shanghai Pharmaceuticals Holding Co., Ltd company belong to?
The Shanghai Pharmaceuticals Holding Co., Ltd industry is Medical Distribution.
How many shares does Shanghai Pharmaceuticals Holding Co., Ltd have in circulation?
The max supply of Shanghai Pharmaceuticals Holding Co., Ltd shares is 741.67M.
What is Shanghai Pharmaceuticals Holding Co., Ltd Price to Earnings Ratio (PE Ratio)?
Shanghai Pharmaceuticals Holding Co., Ltd PE Ratio is 6.60869550 now.
What was Shanghai Pharmaceuticals Holding Co., Ltd earnings per share over the trailing 12 months (TTM)?
Shanghai Pharmaceuticals Holding Co., Ltd EPS is 1.15 USD over the trailing 12 months.
Which sector does the Shanghai Pharmaceuticals Holding Co., Ltd company belong to?
The Shanghai Pharmaceuticals Holding Co., Ltd sector is Healthcare.